Study of Docetaxel in Breast Cancer Patients

NCT00174707 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

998

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile
DRUG: epidoxorubicine, docetaxel, ciclophosphamide, methotrexate, fluorouracile
DRUG: epidoxorubicine, docetaxel, cyclophosphamide

Sponsor

Sanofi